Ertl HC - Search Results

1

Enhancement of recombinant adenovirus vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid.

Tuyishime S, Haut LH, Zhu C, Ertl HC. Tuyishime S, et al. Among authors: ertl hc. Vaccine. 2014 Jun 5;32(27):3386-92. doi: 10.1016/j.vaccine.2014.04.028. Epub 2014 Apr 26. Vaccine. 2014. PMID: 24780251 Free PMC article.

2

Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens.

Schumacher CL, Ertl HC, Koprowski H, Dietzschold B. Schumacher CL, et al. Among authors: ertl hc. Vaccine. 1992;10(11):754-60. doi: 10.1016/0264-410x(92)90510-q. Vaccine. 1992. PMID: 1441731

3

Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines.

Ertl HC, Varga I, Xiang ZQ, Kaiser K, Stephens L, Otvos L Jr. Ertl HC, et al. Vaccine. 1996 Jun;14(9):879-85. doi: 10.1016/0264-410x(96)00005-9. Vaccine. 1996. PMID: 8843629

4

The effect of interferon-gamma on genetic immunization.

Xiang ZQ, He Z, Wang Y, Ertl HC. Xiang ZQ, et al. Among authors: ertl hc. Vaccine. 1997 Jun;15(8):896-8. doi: 10.1016/s0264-410x(96)00269-1. Vaccine. 1997. PMID: 9234542

5

Induction of mucosal immunity with a replication-defective adenoviral recombinant.

Xiang Z, Ertl HC. Xiang Z, et al. Among authors: ertl hc. Vaccine. 1999 Apr 9;17(15-16):2003-8. doi: 10.1016/s0264-410x(98)00449-6. Vaccine. 1999. PMID: 10217600

6

Immune responses to DNA vaccines.

Kowalczyk DW, Ertl HC. Kowalczyk DW, et al. Among authors: ertl hc. Cell Mol Life Sci. 1999 May;55(5):751-70. doi: 10.1007/s000180050330. Cell Mol Life Sci. 1999. PMID: 10379361 Free PMC article. Review.

7

Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16.

Kowalczyk DW, Wlazlo AP, Shane S, Ertl HC. Kowalczyk DW, et al. Among authors: ertl hc. Vaccine. 2001 May 14;19(25-26):3583-90. doi: 10.1016/s0264-410x(01)00070-6. Vaccine. 2001. PMID: 11348726

8

Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost.

Vinner L, Wee EG, Patel S, Corbet S, Gao GP, Nielsen C, Wilson JM, Ertl HCJ, Hanke T, Fomsgaard A. Vinner L, et al. J Gen Virol. 2003 Jan;84(Pt 1):203-213. doi: 10.1099/vir.0.18589-0. J Gen Virol. 2003. PMID: 12533717

9

Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.

Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HC. Xiang ZQ, et al. Among authors: ertl hc. J Virol. 2003 Oct;77(20):10780-9. doi: 10.1128/jvi.77.20.10780-10789.2003. J Virol. 2003. PMID: 14512528 Free PMC article.

10

Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

Pinto AR, Fitzgerald JC, Giles-Davis W, Gao GP, Wilson JM, Ertl HC. Pinto AR, et al. Among authors: ertl hc. J Immunol. 2003 Dec 15;171(12):6774-9. doi: 10.4049/jimmunol.171.12.6774. J Immunol. 2003. PMID: 14662882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters